These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 8831684)

  • 1. Geranylgeraniol causes a decrease in levels of calreticulin and tyrosine phosphorylation of a 36-kDa protein prior to the appearance of apoptotic features in HL-60 cells.
    Nakajo S; Okamoto M; Masuda Y; Sakai I; Ohsawa S; Nakaya K
    Biochem Biophys Res Commun; 1996 Sep; 226(3):741-5. PubMed ID: 8831684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous substrates of sphingosine-dependent kinases (SDKs) are chaperone proteins: heat shock proteins, glucose-regulated proteins, protein disulfide isomerase, and calreticulin.
    Megidish T; Takio K; Titani K; Iwabuchi K; Hamaguchi A; Igarashi Y; Hakomori S
    Biochemistry; 1999 Mar; 38(11):3369-78. PubMed ID: 10079081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of apoptosis in various tumor cell lines by geranylgeraniol.
    Ohizumi H; Masuda Y; Yoda M; Hashimoto S; Aiuchi T; Nakajo S; Sakai I; Ohsawa S; Nakaya K
    Anticancer Res; 1997; 17(2A):1051-7. PubMed ID: 9137448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calreticulin expression is associated with androgen regulation of the sensitivity to calcium ionophore-induced apoptosis in LNCaP prostate cancer cells.
    Zhu N; Wang Z
    Cancer Res; 1999 Apr; 59(8):1896-902. PubMed ID: 10213498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oligosaccharide binding characteristics of the molecular chaperones calnexin and calreticulin.
    Vassilakos A; Michalak M; Lehrman MA; Williams DB
    Biochemistry; 1998 Mar; 37(10):3480-90. PubMed ID: 9521669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calreticulin binding and other biological activities of survival peptide Y-P30 including effects of systemic treatment of rats.
    Cunningham TJ; Jing H; Wang Y; Hodge L
    Exp Neurol; 2000 Jun; 163(2):457-68. PubMed ID: 10833321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of calreticulin as a protein interacting with protein kinase C.
    Rendón-Huerta E; Mendoza-Hernández G; Robles-Flores M
    Biochem J; 1999 Dec; 344 Pt 2(Pt 2):469-75. PubMed ID: 10567230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The fibronectin-derived anti-adhesive peptide III14-2 suppresses adhesion and apoptosis of leukemic cell lines through down-regulation of protein-tyrosine phosphorylation.
    Fukai F; Kamiya S; Ohwaki T; Goto S; Akiyama K; Goto T; Katayama T
    Cell Mol Biol (Noisy-le-grand); 2000 Feb; 46(1):145-52. PubMed ID: 10726980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin K(2) selectively induced apoptosis in ovarian TYK-nu and pancreatic MIA PaCa-2 cells out of eight solid tumor cell lines through a mechanism different from geranylgeraniol.
    Shibayama-Imazu T; Sakairi S; Watanabe A; Aiuchi T; Nakajo S; Nakaya K
    J Cancer Res Clin Oncol; 2003 Jan; 129(1):1-11. PubMed ID: 12618894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphotyrosine protein of molecular mass 30 kDa binds specifically to the positively charged region of the pleckstrin N-terminal pleckstrin homology domain.
    Liu L; Makowske M
    Biochem J; 1999 Sep; 342 ( Pt 2)(Pt 2):423-30. PubMed ID: 10455030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chaperone properties of calreticulin.
    Svaerke C; Houen G
    Acta Chem Scand (Cph); 1998 Jul; 52(7):942-9. PubMed ID: 9661269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel 21-kDa cytochrome c-releasing factor is generated upon treatment of human leukemia U937 cells with geranylgeraniol.
    Masuda Y; Maeda S; Watanabe A; Sano Y; Aiuchi T; Nakajo S; Itabe H; Nakaya K
    Biochem Biophys Res Commun; 2006 Jul; 346(2):454-60. PubMed ID: 16765912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A mathematical model predicts that calreticulin interacts with the endoplasmic reticulum Ca(2+)-ATPase.
    Baker HL; Errington RJ; Davies SC; Campbell AK
    Biophys J; 2002 Feb; 82(2):582-90. PubMed ID: 11806903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Loop" domain is necessary for taxol-induced mobility shift and phosphorylation of Bcl-2 as well as for inhibiting taxol-induced cytosolic accumulation of cytochrome c and apoptosis.
    Fang G; Chang BS; Kim CN; Perkins C; Thompson CB; Bhalla KN
    Cancer Res; 1998 Aug; 58(15):3202-8. PubMed ID: 9699642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Capacitation induces tyrosine phosphorylation of proteins in the boar sperm plasma membrane.
    Flesch FM; Colenbrander B; van Golde LM; Gadella BM
    Biochem Biophys Res Commun; 1999 Sep; 262(3):787-92. PubMed ID: 10471403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein kinase C modulation of insulin receptor substrate-1 tyrosine phosphorylation requires serine 612.
    De Fea K; Roth RA
    Biochemistry; 1997 Oct; 36(42):12939-47. PubMed ID: 9335553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a NPXY motif in growth factor receptor-bound protein 14 (Grb14) and its interaction with the phosphotyrosine-binding (PTB) domain of IRS-1.
    Rajala RV; Chan MD
    Biochemistry; 2005 Jun; 44(22):7929-35. PubMed ID: 15924411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and purification of mammalian calreticulin in Pichia pastoris.
    Andrin C; Corbett EF; Johnson S; Dabrowska M; Campbell ID; Eggleton P; Opas M; Michalak M
    Protein Expr Purif; 2000 Nov; 20(2):207-15. PubMed ID: 11049745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new method for isolating tyrosine kinase substrates used to identify fish, an SH3 and PX domain-containing protein, and Src substrate.
    Lock P; Abram CL; Gibson T; Courtneidge SA
    EMBO J; 1998 Aug; 17(15):4346-57. PubMed ID: 9687503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calreticulin displays in vivo peptide-binding activity and can elicit CTL responses against bound peptides.
    Nair S; Wearsch PA; Mitchell DA; Wassenberg JJ; Gilboa E; Nicchitta CV
    J Immunol; 1999 Jun; 162(11):6426-32. PubMed ID: 10352256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.